Of importance, in patients with fast progressing disease we observed a differential increase in sTNF-RII and CCL16 plasma levels and further decrease in the plasma levels of leptin, i.e., significantly decreased leptin when compared to plasma levels observed in slow progressing ALS. Here, LEP is linked to amyotrophic lateral sclerosis.